GGrantIndex
← Leaderboards

Dongmin Liu

Virginia Polytechnic Inst And St Univ

$4,464,004
Attributed
$4,464,004
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $523.1K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,464,004 · 4

By mechanism

R01$3,380,550 · 2
R21$1,083,454 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Mediating

Research focus

MediatingAmericanPathway InteractionsMolecularPreventDiabetes MellitusHyperglycemiaDiabetic MouseIn VivoDiabeticAffectCostObesityGrantChronicSignal PathwayGenisteinInnovationCyclic Amp-Dependent Protein KinasesCyclic AmpAnimalsPlayFunctional DisorderEnergy Metabolism

Grant awards (13)

Discovery and characterization of a novel natural product for the treatment of both diabetes and obesity$476,912
R01 · FY2025 · DK · contact PI
Discovery and characterization of a novel natural product for the treatment of both diabetes and obesity$457,835
R01 · FY2024 · DK · contact PI
Discovery and characterization of a novel natural product for the treatment of both diabetes and obesity$523,140
R01 · FY2023 · DK · contact PI
Identification and molecular characterization of anti-diabetic flavonoids$390,252
R01 · FY2016 · AT · contact PI
Identification and molecular characterization of anti-diabetic flavonoids$379,244
R01 · FY2015 · AT · contact PI
Identification and molecular characterization of anti-diabetic flavonoids$379,887
R01 · FY2014 · AT · contact PI
Identification and molecular characterization of anti-diabetic flavonoids$380,478
R01 · FY2013 · AT · contact PI
Identification and molecular characterization of anti-diabetic flavonoids$392,802
R01 · FY2012 · AT · contact PI
Genistein for the Prevention and Treatment of Diabetic Vascular Inflammation$237,750
R21 · FY2009 · AT · contact PI
Genistein for the prevention and treatment of diabetic vascular inflammation$213,114
R21 · FY2009 · AT · contact PI
Genistein and cAMP signaling in vascular endothelium$234,714
R21 · FY2008 · AT · contact PI
Genistein for the Prevention and Treatment of Diabetic Vascular Inflammation$198,125
R21 · FY2008 · AT · contact PI
Genistein and cAMP signaling in vascular endothelium$199,751
R21 · FY2007 · AT · contact PI